InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Robin Sherrington, Directeur Exécutif. Director active across 2 companies, notably Xenon Pharmaceuticals Inc.. In total, 5 disclosures have been published. Activity tracked since 28 May 2021. The latest transaction was disclosed on 7 March 2024 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Robin Sherrington
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
1,234 shares@ US$9.8519.3% of flowCommon SharesSEC:0000950170-24-028795:0
8,398 shares0Common SharesSEC:0000950170-24-000304:0
17,488 shares@ US$2.6780.7% of flowCommon SharesSEC:0001209191-22-048508:0
1,234 shares@ US$3.679.7% of flowCommon SharesSEC:0001209191-22-017318:0
12,345 shares@ US$3.7690.3% of flowCommon SharesSEC:0001209191-21-036802:0
5 of 5 declarations
About Robin Sherrington
Robin Sherrington is Executive Vice President of Strategy and Innovation at Xenon Pharmaceuticals Inc. She is responsible for strategic leadership and innovation within the company, contributing to its development.
